Price Controls | Citizens Against Government Waste
The WasteWatcher: The Staff Blog of Citizens Against Government Waste

Price Controls

House Speaker Pelosi's Bizarre Drug Price Negotiation Plan

Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal.  According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market.  If no agreement can be reached, the Government Accountability Office would act as an arbitrator and oversee a dispute resolution.

U.S. Should Not Import Foreign Price Controls on Drugs

On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the United Nations (UN), in Geneva, Switzerland. This assembly is held annually and attended by delegations from the 150 WHO member states, including the United States.

Conservatives Behaving Badly on Drug Pricing

Conservative politicians like to say they are for free markets, competition, and property rights to promote innovation and lower prices of goods.  But when it comes to pharmaceuticals, too many of them go careening off the freedom road to promote socialist policies.  They fail to recognize the years of expensive clinical trials and complicated protocols, the thousands of failed prospects that still must be paid for, and the lengthy Food and Drug Administration (FDA) approval process to get just one drug into the marketplace. 

Binding Arbitration for Medicare Part B: Price Controls by Another Name

The Trump administration proposed using an International Pricing Index in October 2018 to reimburse providers for drugs administered under Medicare Part B.  These drugs require the involvement of a physician and include, but are not limited to, infused and injectable drugs, some antigens, drugs used with durable medical equipment, and blood clotting factors.  Instead of reimbursing the provider of Part B d

They’re Baaaaack – The Sequel

In their never-ending quest to run roughshod and exert control over the research-intensive biopharmaceutical industry, socialists in Congress have introduced various price-control bills.  For some reason they continue to think innovative drugs that cure cancer or other chronic diseases, such as hepatitis C, are whipped up in a back room with a 1970s-style “

Using an International Pricing Index is NOT the Way to Lower Drug Costs

On December 6, John O’Brien, the senior advisor on drug pricing reform to Health and Human Services (HHS) Secretary Alex Azar, published a blog, entitled, “How the IPI Model Would Introduce New Market Competition to Medicare Drug Spending.”  The blog left a lot of fiscal conservatives and patient-centered, free-market healthcare advocates scratching their heads.  Mr.

President Trump's Drug Costs Proposals Coming Soon

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

Sign Up for Email Updates!Click Here!

View Archives

Posts by Author

Posts by Tag

Big Government (152) Obamacare (84) Congress (78) Waste (74) Healthcare (74) Budget (72) Uncategorized (56) Telecommunications (50) Internet (49) Debt (47) Technology (46) Deficit (44)